Property Valuation

Our Hong Kong office welcomed ten students and their professors from the master course of Real Estate Economics and Management of the HAWK University of Applied Science and Art in Germany to enjoy a wonderful breakfast sharing session last week.
 
Our Managing Director, Mr. Vincent Pang and Director of Fixed-Asset Valuation Advisory services, Mr. Oswald Au, spoke on the topics including, Hong Kong’s real estate market and land system, the unique characteristics of Hong Kong’s property market, the housing policy and strategy implemented by the HKSAR government, as well as the development of the Greater Bay Area and the role of Hong Kong in it.
 
Vincent also shared his experience in founding AVISTA Group and the challenges and success factors as an entrepreneur in Hong Kong.
 
<img src="../../../../../uploads/HAWK1_c7ec30953b.png" width="700" />

banner1

Hawk University’s Visit to AVISTA Hong Kong Office

AVISTA had the honor of being invited as a speaker by the China Appraisal Society (CAS) for the Financial Instruments and Assets Valuation Training in 6 consecutive years. This training, held on October 10, 2024, at the esteemed Shanghai National Accounting Institute, provided a platform for industry experts to share insights and knowledge with public valuers.
 
During the training session, our Managing Partner, Mr. Vincent Pang, and our Senior Manager of Business Valuation Advisory Services in the Shanghai office, Ms. Irene Ma, delivered a lecture on the valuation methods of preferred shares or common shares with preferential rights embedded and derivative financial instruments. Their presentation included detailed case analyses and practical real-life applications, providing valuable perspectives and expertise to the public valuers.
 
AVISTA remains steadfast in our commitment to knowledge sharing and industry advancement, and we are proud to contribute our expertise to the development of industry talents and the broader professional community.
 
<img src="../../../../../uploads/20241010_479510e62d.jpg" width="500" />

adventure-1840310_1920

As a Speaker at the China Appraisal Society (CAS) Financial Instruments and Assets Valuation Training

AVISTA is honored to have been the sponsor of Together Run For National Day 2024. The run, which took place on October 6th, was a resounding success, and we extend our congratulations to all the participants for their dedication and achievement in completing the run.
 
This event held special significance as it not only marked the 75th anniversary of the founding of the People’s Republic of China but also served as a platform to bring together individuals from diverse backgrounds. The overarching aim of the run was to promote unity and inclusivity within society. Following the deduction of expenses, all proceeds from the run were generously donated to Hong Kong Rehabilitation Power and PHAB Community Limited to support their efforts in promoting PHAB (Physically Handicapped and Able-Bodied) initiatives.
 
AVISTA is proud to have been a part of this significant event and to have contributed to its success. We remain committed to supporting initiatives that promote social cohesion, diversity, and inclusivity, and we look forward to continuing our efforts in making a positive impact in the community.

Pic1.jpg

As the Sponsor of Together Run For National Day 2024

Congratulations to Zhejiang Taimei Medical Technology Co.,Ltd. (2576.HK) on its successful Listing on the Mainboard of HKSE on 8 October 2024
 
Zhejiang Taimei Medical Technology Co.,Ltd. (“Taimei”) is a digital solution provider focused on the pharmaceutical and medical device industry in China. The software is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. These cloud-based software covers critical use cases in the research and development and commercialization of innovative drugs and medical devices. In addition to software, Taimei also provide a range of digital services, primarily assisting customers with independent reading of medical images, achieving efficient site management organization resource distribution and execution, offering pharmacovigilance services and other services to support customers’ the research and development and commercialization activities.
 
With regard to this listing application, AVISTA Group is honoured to be engaged in providing valuation services in relation to employee stock plan, M&amp;A and financing transactions.
 
Congratulations again to Zhejiang Taimei Medical Technology Co.,Ltd. (2576.HK) on its successful listing. The issue price is HKD 13.00 per share, and the amount of funds raised is HKD 259.5 million.
 
<img src="../../../../../uploads/Slide1_8c317e565a.png" width="500" />